Multicentric Castleman's disease and HIV.

Proc (Bayl Univ Med Cent)

Department of Pathology, Section of Hematopathology (Krause), and the Department of Hematology/Oncology (Robinson, Vance), Baylor University Medical Center at Dallas and the Baylor Charles A. Sammons Cancer Center at Dallas.

Published: January 2014

Multicentric Castleman's disease (MCD) is a rare lymphoproliferative disorder found with a higher frequency in HIV-seropositive patients. Human herpes virus 8 is found in virtually all cases of HIV-associated MCD. The majority of cases of MCD in patients with HIV are also associated with Kaposi's sarcoma. The dysregulated production of human IL-6 is thought to be an important factor in the pathogenesis of MCD. HIV-seropositive individuals with MCD have a significantly greater risk of developing non-Hodgkin lymphomas than their HIV-seronegative counterparts. MCD occurring in HIV patients has been associated with a poor prognosis. With newer therapy regimens, it is hoped that the prospects of HIV-infected patients with MCD will improve.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862127PMC
http://dx.doi.org/10.1080/08998280.2014.11929044DOI Listing

Publication Analysis

Top Keywords

multicentric castleman's
8
castleman's disease
8
mcd
7
disease hiv
4
hiv multicentric
4
disease mcd
4
mcd rare
4
rare lymphoproliferative
4
lymphoproliferative disorder
4
disorder higher
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!